Charles Schwab Investment Management »

Peregrine Pharmaceuticals shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2M 486k 6.50
2023-09-30 $4.6M 491k 9.44
2023-06-30 $6.7M 479k 13.97
2023-03-31 $8.8M 471k 18.76
2022-12-31 $6.4M 466k 13.77
2022-09-30 $8.6M 449k 19.12
2022-06-30 $6.7M 437k 15.26
2022-03-31 $9.0M 443k 20.37
2021-12-31 $14M 466k 29.18
2021-09-30 $9.8M 456k 21.57
2021-06-30 $3.8M 148k 25.65
2021-03-31 $2.7M 149k 18.24
2020-12-31 $1.6M 137k 11.55
2020-09-30 $996k 131k 7.63
2020-06-30 $893k 136k 6.57
2020-03-31 $695k 136k 5.11
2019-12-31 $1.0M 132k 7.67
2019-09-30 $746k 141k 5.30
2019-06-30 $790k 141k 5.61
2019-03-31 $439k 103k 4.25
2018-12-31 $449k 110k 4.10
2018-09-30 $752k 110k 6.87
2018-06-30 $371k 95k 3.93